BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22269400)

  • 21. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.
    Kwon AK; Dibiase SJ; Wang B; Hughes SL; Milcarek B; Zhu Y
    Cancer; 2009 Feb; 115(4):890-8. PubMed ID: 19132728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
    Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
    Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer.
    Guckenberger M; Bachmann J; Wulf J; Mueller G; Krieger T; Baier K; Richter A; Wilbert J; Flentje M
    Radiother Oncol; 2010 Jan; 94(1):53-9. PubMed ID: 20079550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11).
    Park HJ; Chang AR; Seo Y; Cho CK; Jang WI; Kim MS; Choi C
    Anticancer Res; 2015 Sep; 35(9):5103-10. PubMed ID: 26254414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.
    Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto T; Sakamoto M; Mitsumori M; Shibuya K; Araki N; Yano S; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1427-31. PubMed ID: 16169670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.
    King CR; Brooks JD; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):877-82. PubMed ID: 21300474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma.
    Price TR; Perkins SM; Sandrasegaran K; Henderson MA; Maluccio MA; Zook JE; Tector AJ; Vianna RM; Johnstone PA; Cardenes HR
    Cancer; 2012 Jun; 118(12):3191-8. PubMed ID: 22025126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
    Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M
    Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma.
    Pai PC; Chuang CC; Wei KC; Tsang NM; Tseng CK; Chang CN
    Head Neck; 2002 Aug; 24(8):748-53. PubMed ID: 12203799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
    King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome in children with recurrent craniopharyngioma after primary surgery.
    Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
    Cancer J; 2000; 6(6):388-93. PubMed ID: 11131489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage stereotactic reirradiation using the CyberKnife for the local recurrence of nasal or paranasal carcinoma.
    Iwata H; Tatewaki K; Inoue M; Yokota N; Sato K; Shibamoto Y
    Radiother Oncol; 2012 Sep; 104(3):355-60. PubMed ID: 22398314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord.
    Choi CY; Adler JR; Gibbs IC; Chang SD; Jackson PS; Minn AY; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):499-506. PubMed ID: 20133079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer.
    Roh KW; Jang JS; Kim MS; Sun DI; Kim BS; Jung SL; Kang JH; Yoo EJ; Yoon SC; Jang HS; Chung SM; Kim YS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1348-55. PubMed ID: 19117695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer.
    Kim JH; Kim MS; Yoo SY; Lim SM; Lee GH; Yi KH
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):338-43. PubMed ID: 20172377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer.
    Roeder F; Treiber M; Oertel S; Dinkel J; Timke C; Funk A; Garcia-Huttenlocher H; Bischof M; Weitz J; Harms W; Hensley FW; Buchler MW; Debus J; Krempien R
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1381-8. PubMed ID: 17275208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.